In vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage

Song Huang,1 Samuel Constant,1 Barbara De Servi,2 Marisa Meloni,2 Josip Culig,3 Marco Bertini,4 Amina Saaid5 1Epithelix, Geneva, Switzerland; 2Department of in Vitro Research, VitroScreen, Milan, 20149, Italy; 3Department of Pharmacology, University of Applied Health Sciences, Zagreb, 10000, Croatia...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Huang S, Constant S, De Servi B, Meloni M, Culig J, Bertini M, Saaid A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Common cold hypertonic seawater nasal irrigation pathogens ATP release decongestion Medical technology R855-855.5
Acceso en línea:	https://doaj.org/article/625123bbfe344642b35a13017eee7343
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:625123bbfe344642b35a13017eee7343
record_format	dspace
spelling	oai:doaj.org-article:625123bbfe344642b35a13017eee73432021-12-02T10:51:48ZIn vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage1179-1470https://doaj.org/article/625123bbfe344642b35a13017eee73432019-09-01T00:00:00Zhttps://www.dovepress.com/in-vitro-safety-and-performance-evaluation-of-a-seawater-solution-enri-peer-reviewed-article-MDERhttps://doaj.org/toc/1179-1470Song Huang,1 Samuel Constant,1 Barbara De Servi,2 Marisa Meloni,2 Josip Culig,3 Marco Bertini,4 Amina Saaid5 1Epithelix, Geneva, Switzerland; 2Department of in Vitro Research, VitroScreen, Milan, 20149, Italy; 3Department of Pharmacology, University of Applied Health Sciences, Zagreb, 10000, Croatia; 4R&D Department, Laboratori Baldacci SpA, Pisa, Italy; 5Department of R&D and Innovation, Laboratoire Fumouze, Levallois-Perret, 92686, FranceCorrespondence: Marco BertiniLaboratori Baldacci SpA, Via S. Michele degli Scalzi, 73, 56124 Pisa, ItalyTel +39 5 031 3271Fax +39 5 057 0170Email bertini@baldaccilab.comBackground: The common cold is a viral infectious disease with symptoms such as runny nose, sore throat, and mainly, nasal congestion. State-of-the-art therapeutic approaches focus on alleviating the symptoms of this disease by non-invasive and simple-to-use methods. Nasal irrigation is one of the most accepted approaches to ease nasal congestion which, if left untreated, has a negative impact on the quality of life of patients.Purpose: In this study, the safety and efficacy of a novel hypertonic seawater solution for nasal lavage enriched with hyaluronic acids, eucalyptus oil, copper, and manganese salts (Stérimar Stop & Protect Cold and Flu; SSPCF) have been investigated in vitro.Methods: An in vitro 3D reconstituted human nasal epithelium tissue model, MucilAir™, has been used in this study to investigate the safety of SSPCF on nasal epithelium by measuring transepithelial electrical resistance (TEER), lactate dehydrogenase (LDH), and interleukin-8 (IL-8) secretion. The efficacy of SSPCF was measured by mucociliary clearance (MCC), ATP release, Alcian blue and aquaporin (AQP3) stainings.Results: SSPCF treatment respected nasal epithelium tissue integrity and enhanced barrier function without inducing a cytotoxic response. Secreted LDH and IL-8 levels were similar to untreated controls. MCC rate was increased 2.5-fold and ATP release decreased 87% upon SSPCF treatment, indicating improved decongestion activity. SSPCF treatment after hypotonic stress helped recover cellular organization, as shown by Alcian blue and AQP3 staining assays.Conclusion: SSPCF appears as a safe and effective nasal irrigation formula that may alleviate the symptoms associated with common cold such as nasal congestion.Keywords: common cold, hypertonic seawater, nasal irrigation, pathogens, ATP release, decongestionHuang SConstant SDe Servi BMeloni MCulig JBertini MSaaid ADove Medical PressarticleCommon coldhypertonic seawaternasal irrigationpathogensATP releasedecongestionMedical technologyR855-855.5ENMedical Devices: Evidence and Research, Vol Volume 12, Pp 399-410 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Common cold hypertonic seawater nasal irrigation pathogens ATP release decongestion Medical technology R855-855.5
spellingShingle	Common cold hypertonic seawater nasal irrigation pathogens ATP release decongestion Medical technology R855-855.5 Huang S Constant S De Servi B Meloni M Culig J Bertini M Saaid A In vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage
description	Song Huang,1 Samuel Constant,1 Barbara De Servi,2 Marisa Meloni,2 Josip Culig,3 Marco Bertini,4 Amina Saaid5 1Epithelix, Geneva, Switzerland; 2Department of in Vitro Research, VitroScreen, Milan, 20149, Italy; 3Department of Pharmacology, University of Applied Health Sciences, Zagreb, 10000, Croatia; 4R&D Department, Laboratori Baldacci SpA, Pisa, Italy; 5Department of R&D and Innovation, Laboratoire Fumouze, Levallois-Perret, 92686, FranceCorrespondence: Marco BertiniLaboratori Baldacci SpA, Via S. Michele degli Scalzi, 73, 56124 Pisa, ItalyTel +39 5 031 3271Fax +39 5 057 0170Email bertini@baldaccilab.comBackground: The common cold is a viral infectious disease with symptoms such as runny nose, sore throat, and mainly, nasal congestion. State-of-the-art therapeutic approaches focus on alleviating the symptoms of this disease by non-invasive and simple-to-use methods. Nasal irrigation is one of the most accepted approaches to ease nasal congestion which, if left untreated, has a negative impact on the quality of life of patients.Purpose: In this study, the safety and efficacy of a novel hypertonic seawater solution for nasal lavage enriched with hyaluronic acids, eucalyptus oil, copper, and manganese salts (Stérimar Stop & Protect Cold and Flu; SSPCF) have been investigated in vitro.Methods: An in vitro 3D reconstituted human nasal epithelium tissue model, MucilAir™, has been used in this study to investigate the safety of SSPCF on nasal epithelium by measuring transepithelial electrical resistance (TEER), lactate dehydrogenase (LDH), and interleukin-8 (IL-8) secretion. The efficacy of SSPCF was measured by mucociliary clearance (MCC), ATP release, Alcian blue and aquaporin (AQP3) stainings.Results: SSPCF treatment respected nasal epithelium tissue integrity and enhanced barrier function without inducing a cytotoxic response. Secreted LDH and IL-8 levels were similar to untreated controls. MCC rate was increased 2.5-fold and ATP release decreased 87% upon SSPCF treatment, indicating improved decongestion activity. SSPCF treatment after hypotonic stress helped recover cellular organization, as shown by Alcian blue and AQP3 staining assays.Conclusion: SSPCF appears as a safe and effective nasal irrigation formula that may alleviate the symptoms associated with common cold such as nasal congestion.Keywords: common cold, hypertonic seawater, nasal irrigation, pathogens, ATP release, decongestion
format	article
author	Huang S Constant S De Servi B Meloni M Culig J Bertini M Saaid A
author_facet	Huang S Constant S De Servi B Meloni M Culig J Bertini M Saaid A
author_sort	Huang S
title	In vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage
title_short	In vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage
title_full	In vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage
title_fullStr	In vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage
title_full_unstemmed	In vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage
title_sort	in vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/625123bbfe344642b35a13017eee7343
work_keys_str_mv	AT huangs invitrosafetyandperformanceevaluationofaseawatersolutionenrichedwithcopperhyaluronicacidandeucalyptusfornasallavage AT constants invitrosafetyandperformanceevaluationofaseawatersolutionenrichedwithcopperhyaluronicacidandeucalyptusfornasallavage AT deservib invitrosafetyandperformanceevaluationofaseawatersolutionenrichedwithcopperhyaluronicacidandeucalyptusfornasallavage AT melonim invitrosafetyandperformanceevaluationofaseawatersolutionenrichedwithcopperhyaluronicacidandeucalyptusfornasallavage AT culigj invitrosafetyandperformanceevaluationofaseawatersolutionenrichedwithcopperhyaluronicacidandeucalyptusfornasallavage AT bertinim invitrosafetyandperformanceevaluationofaseawatersolutionenrichedwithcopperhyaluronicacidandeucalyptusfornasallavage AT saaida invitrosafetyandperformanceevaluationofaseawatersolutionenrichedwithcopperhyaluronicacidandeucalyptusfornasallavage
_version_	1718396534530244608

In vitro safety and performance evaluation of a seawater solution enriched with copper, hyaluronic acid, and eucalyptus for nasal lavage

Ejemplares similares